}

Friday, 27 January 2017

27 January 2017 - Views & News

MARKET INSIGHT

 Indian markets are likely to open on a negative note based on the global cues. Bias remains positive and support for the day is placed at 8541 levels.

Nifty Spot Levels

Support 8541 – 8398
Resistance 8654 - 8678

GLOBAL MARKET & INTERNATIONAL DATA UPDATE

• US stocks were little changed on Thursday as investors paused following a two-day rally that pushed the Dow Jones Industrial Average above the 20,000 mark, while the latest wave of earnings rolled in.
• Trump's business-friendly decisions since taking office on Friday include signing executive orders to reduce regulatory burden on domestic manufacturers and clearing the way for the construction of two oil pipelines.
• The Dow Jones Industrial Average rose 32.40 points, or 0.16 percent, to close at 20,100.91.
Market Update:

Sgx Nifty +40 pts(Sgx 8654)(Nifty Fut 8614) ‎Dow +32.40 pts ,Nsdq -1.16 pts , S&P -1.69 pts , Bovespa +350 pts , Ftse -2 pts  , Dax +42 pts  , Cac -10 pts , Nikkei  +288 pts now , Crude @ $53.74 brl (-0.04), Brent @ $56.24 brl (+1.16) , Gold @ $1187.40 (-2.40), Silver @ $16.77 (-0.08), Euro @ $1.0683, JPY @ $114.4300, INR @ $68.0750

Today's Key Result 27th Jan

Advani Hotels, Colpal, Eveready, Geojit BNPP, Guj Alkali, India Cement, Ind Nippon, ITC, Just Dial, KKCL, Shanti Gear, Sundaram Fin, Tanla, Tata Coffee, Zuari Agro

TOP NEWS

ALERT: As per Bloomberg, Singapore Complex GRM has recovered sharply by 22% to $6.9/bbl in January-2017 till date as compared to the average of $5.7/bbl in December-2016. Positive for OMCs and Reliance Industries

Sun Pharma gets USFDA approval for generic Ambein CR; used as sedative primarily used for the treatment of insomnia – Positive for Sun Pharma

Aurobindo gets USFDA approval for Dalfampridine tablets; used to treat improve walking in the adults suffering with multiple sclerosis- Positive for Aurobindo

GAIL has recommended bonus issue of 1:3 (one bonus share for every 3 shares held) and approved interim dividend of Rs8.5/sh (85% of FV of Rs10/sh).

Dilip Buildcon:  The company wins Rs911 crore hybrid annuity project in Maharashtra – Positive for the stock
National Highways Authority of India has declared Dilip Buildcon, the successful bidder (L-1) for the project “four laning of Turjapur-Ausa section of NH-361 on Hybrid Annuity Mode in the state of Maharashtra at a project cost of Rs911.07 crores having length of 67.428 Km and Completion period of 24 Months. The development is positive for Dilip Buildcon.

Dr Reddy in Focus: South Korea's Mezzion, a drug company is seeking damages from Dr Reddy's in a New Jersey court for committing fraud by hiding significant deficiencies and misrepresenting compliance in its manufacturing practices. The suit states that Dr Reddy's repeatedly represented to Mezzion that it was compliant with FDA regulations, and that it hid its misconduct from Mezzion. The suit also states that Dr. Reddy's misconduct was the sole reason given by the FDA to deny approval of Mezzion's new drug application (NDA) for udenafil for the treatment of erectile dysfunction (ED) and for FDA's refusal to grant marketing approval of Mezzion's udenafil finished drug product. – Negative for Dr Reddy.

European car major Peugeot inks JVs with Hindustan Motors for assembly and distribution of vehicles in India by 2020 – positive……(details in Other news)


Pharma sector in focus: Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has slashed the prices of around 33 essential medicines, bringing down their retail prices by 30-50% - Negative for companies like Alkem, GSK Pharma, Alembic, Cipla, Dr Reddy (details in Other news)

OTHER NEWS

European car major Peugeot inks JVs with Hindustan Motors for assembly and distribution of vehicles in India by 2020 - positive
European auto giant Peugeot has signed joint venture agreement with Hindustan Motors Finance Corporation Limited) which is a subsidiary of Hindustan Motors for the assembly and distribution of PSA passenger cars in India by 2020. As part of the agreement, the PSA Group will hold a majority stake in the joint-venture company. The manufacturing sites for vehicle assembly will be based in Tamil Nadu. Hindustan Motors has a manufacturing plant at Tiruvallur near Chennai which makes products of Mitsubishi. The initial manufacturing capacity will be set at about 1,00,000 vehicles per year and will be followed by incremental investment to support a progressive ramp-up of the long term project. 

Tata Motors sees recovery in CV business; expect January 2017 sales to be flat; positive read thru
Tata Motors has stated that the CV segment is witnessing recovery and expects sales in the month of January 2017 to match sales in the corresponding month last year. CV sales had been under pressure post demonetization (November and December 2016 sales dropped on yoy basis) Tata Motors aims to become no 3 CV player globally by FY2019 helped by strong sales in the Indian market. It launched a fully electric and a hybrid bus, with indicative prices ranging between Rs 1.6 crore and Rs 2 crore

Maruti Suzuki launches limited edition of Swift Dzire
Maruti Suzuki has launched the Allure limited edition of the Swift Dzire. The new Allure edition of Dzire gets chrome garnish on the front grille, chrome inserts on the fog lamp, side skirts and an 'Allure' moniker below the variant badge. In addition, the compact sedan also gets chrome inserts on the boot and window frames. Inside, Allure edition gets a new dual-tone seat colour, dual-tone steering wheel cover, Allure pillows and ambient lighting. The company is also offering an optional 8-inch subwoofer with 4-channel amplifier and more powerful component speakers in the integrated audio system.

Pharma sector in focus: Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has slashed the prices of around 33 essential medicines, bringing down their retail prices by 30-50% - Negative for companies like Alkem, GSK Pharma, Alembic, Cipla, Dr Reddy
These 33 drugs includes anti-allergics used for common cold and cough, antibiotics and drugs used to treat ulcerative colitis, arthritis, psoriasis, gastroesophageal reflux disease (Gerd) and tuberculosis. The 33 drugs have been divided into two categories. While the regulator has brought 11 new drugs under price control, prices of 22 new drugs whose prices were already capped have been further reduced. All the 33 drugs are part of the revised National List of Essential Medicines, 2015

Dredging Corporation of India secures Rs102 Crore International Contract for Dredging in Pussur Channel from Mongla Port to Rampal Power Plant, Bangladesh in Global Competitive Bidding. The development is positive for Dredging Corporation of India.

 MORE NEWS

Data analysts will match your deposits with ITR, TDS
Idea, Vodafone giving adequate PoI to Jio: Trai
Govt may revive Kolar gold mines with $2 bn reserves
Withdrawal limits likely to go away by Feb-end
India is the sixth great power in 2017: US magazine
US new home sales hit post-crisis record in 2016
Ratan Tata-Cyrus Mistry row: Sebi finds no violations
Trade deficit may range b/w $100-110 bn: Report
Survey indicates decline in business sentiment outlook for Q4: RBI
South Korean firm sues Dr Reddy's in US court
NCLT accepts Synergies Dooray's application for insolvency
Petrochemical majors step on expansion gas pedal
Hurdles in digital transactions temporary: NPCI
Consumers drive UK eco, defying expected Brexit vote hit
RBS sets aside $4 bn for 'painful legacy' of US loan mis-selling
High govt debt limits room for quick deficit reduction: Moody’s
Jaitley eyes tax giveaways, state investment in Budget
Tata Steel plans to increase capacity of Kalinganagar plant
Wipro Q3 net profit falls 5.6% on higher costs
FSSAI notifies comprehensive regulations for food recall
Peugeot maker to drive back into India with CK Birla group
Reliance Jio impact: Airtel to switch to VoLTE in key markets
BlackRock’s $1 trillion JPMorgan move shows cost strategy
GVK sole bidder for Navi Mumbai airport
Fidelity Investments slashes Flipkart’s valuation by over a third
Donald Trump finds unlikely ally in Unilever CEO Paul Polman
Sebi bars Vijay Mallya, six others from securities market
RBI prohibits investments in 'non-cooperative countries'
British Steel to reverse Tata Steel pay cuts on staff at UK plant
Moody's downgrades Rel Com credit rating to B2
Consolidation in realty sector to gain momentum post notes ban
Maruti Suzuki net zooms 47.5%
Tata Steel aims 20% revenue from service, solutions biz
Only 3% jewellers have hallmarking certification
BSE IPO oversubscribed nearly 12 times
Parliament must vote before UK can trigger Brexit, rules top court
Johnson & Johnson to buy Actelion for $30b

 STOCK IN NEWS 

1. Japan's Bank of Tokyo-Mitsubishi UFJ (BTMU), part of the Mitsubishi UFJ Financial Group (MUFG), is taking aggressive bets in Indian pharmaceuticals.
2. IFC plans to invest $10 million in Zinka Logistics
3. United Spirits' matter: Sebi bars Mallya, six others from securities market
4. Wipro to acquire Brazilian IT firm for $8.7 mn
5. Tata Motors launches electric bus at Rs 1.6 cr
6. Tata Steel aims 20% revenue from service, solutions businesses
7. RINL in talks with SBI for Rs 1,600 crore debt for UP project
8. China power firm seeks to enter power transmission sector
9. NTPC is supposedly dragging its feet on the proposed expansion of its 3000 Mw super thermal power station at Kaniha, some 180 km from Bhubaneshwar.
10. Idea moves Delhi High Court against TRAI penalty recommendation
11. Cyient acquires Certon Software in fifth deal in under three years
12. Siemens announces receiving order worth Rs 366 crore from ONGC

No comments: